Literature DB >> 10480128

Field evaluation of new water-dispersible granular formulations of Bacillus thuringiensis ssp. israelensis and Bacillus sphaericus against Culex mosquitoes in microcosms.

T Su1, M S Mulla.   

Abstract

A variety of formulations of Bacillus thuringiensis var. israelensis de Barjac (B.t.i.) and Bacillus sphaericus Neide (B.s.) have been studied for mosquito control under laboratory and field conditions. High efficacy, specificity, low risk of development of resistance, long shelf-life, and transportability, as well as the safety to nontarget organisms of these 2 microbial agents have been well documented. Some of the currently available formulations of B.t.i. and B.s. have low potency per unit mass. Research and development efforts are focusing on commercializing formulations with high potency and low minimum effective dosage that are suitable for long-distance shipment. To achieve this goal, new water-dispersible granule (WDG) formulations of both microbial agents were prepared and made available by Abbott Laboratories for evaluation. The newly developed WDGs of B.t.i. and B.s. with high potency dispersed readily in water with gentle agitation. These WDGs were evaluated and the minimum effective dosages were determined in microcosms against natural populations of Culex mosquitoes. The minimum effective dosage for B.t.i. WDGs with 4,000 International Toxic Units (ITU)/mg was 0.27-0.53 lb/acre which yielded significant control for up to 7-12 days. The minimum effective dosage for B.s. WDGs with 350-630 ITU/mg was 0.05-0.10 lb/acre, which yielded significant control of immature mosquitoes for up to 14-20 days.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10480128

Source DB:  PubMed          Journal:  J Am Mosq Control Assoc        ISSN: 8756-971X            Impact factor:   0.917


  7 in total

1.  Bacillus thuringiensis var. israelensis (Bti) provides residual control of Aedes aegypti in small containers.

Authors:  Scott A Ritchie; Luke P Rapley; Seleena Benjamin
Journal:  Am J Trop Med Hyg       Date:  2010-06       Impact factor: 2.345

2.  Immobilization of alginate-encapsulated Bacillus thuringiensis var. israelensis containing different multivalent counterions for mosquito control.

Authors:  G Prabakaran; S L Hoti
Journal:  Curr Microbiol       Date:  2008-04-04       Impact factor: 2.188

3.  Influence of amino nitrogen in the culture medium enhances the production of delta-endotoxin and biomass of Bacillus thuringiensis var. israelensis for the large-scale production of the mosquito control agent.

Authors:  G Prabakaran; S L Hoti
Journal:  J Ind Microbiol Biotechnol       Date:  2008-05-29       Impact factor: 3.346

4.  Efficacy of Bacillus thuringiensis var. israelensis against malaria mosquitoes in northwestern Burkina Faso.

Authors:  Peter Dambach; Valérie R Louis; Achim Kaiser; Saidou Ouedraogo; Ali Sié; Rainer Sauerborn; Norbert Becker
Journal:  Parasit Vectors       Date:  2014-08-15       Impact factor: 3.876

5.  Use of Bacillus thuringiensis var israelensis as a viable option in an Integrated Malaria Vector Control Programme in the Kumasi Metropolis, Ghana.

Authors:  Rita Nartey; Ellis Owusu-Dabo; Thomas Kruppa; Sandra Baffour-Awuah; Augustina Annan; Samuel Oppong; Norbert Becker; Kwasi Obiri-Danso
Journal:  Parasit Vectors       Date:  2013-04-22       Impact factor: 3.876

Review 6.  The biological control of the malaria vector.

Authors:  Layla Kamareddine
Journal:  Toxins (Basel)       Date:  2012-09-19       Impact factor: 4.546

7.  Routine implementation costs of larviciding with Bacillus thuringiensis israelensis against malaria vectors in a district in rural Burkina Faso.

Authors:  Peter Dambach; Michael Schleicher; Hans-Christian Stahl; Issouf Traoré; Norbert Becker; Achim Kaiser; Ali Sié; Rainer Sauerborn
Journal:  Malar J       Date:  2016-07-22       Impact factor: 2.979

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.